SLFN11 and small cell carcinoma: The small cell carcinoma cell line SW-13 expresses SLFN11 both at the protein and transcription levels (Supplementary Fig. S4A; ref. 35) and, as expected (50), was found the most sensitive to topotecan among the four cell lines examined (Supplementary Fig. S4B).